Clinical Trials Browser

Phase 1/2 × Lymphoma, Mantle-Cell × ricolinostat × Clear all

NCT02091063 2024-08-06

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Phase 1/2 Terminated

23 enrolled 6 charts

LymphoidOther hematologic neoplasm

Lymphoma, Hematologic Neoplasms, Lymphoma, Mantle-Cell